The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationAn Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Self-citationOakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F.-T., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 819
Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report
Cherny, N., Ripamonti, C., Pereira, J., Davis, C., Fallon, M., McQuay, H., Mercadante, S., Pasternak, G., Ventafridda, V., & for the Expert Working Group of the European Association of Palliative Care Network (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2542 · Cited by 626
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567
Morphine Activates Opioid Receptors without Causing Their Rapid Internalization
Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552
Daaka, Y., Luttrell, L. M., Ahn, S., Della Rocca, G. J., Ferguson, S. S. G., Caron, M. G., & Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.685 · Cited by 542
Zhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 494
Opioids: first lessons from knockout mice
Kieffer, B. L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01279-6 · Cited by 489
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Gurevich, V. V., & Gurevich, E. V. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.008 · Cited by 472
Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
Functional Dissociation of μ Opioid Receptor Signaling and Endocytosis
Whistler, J. L., Chuang, H.-H., Chu, P., Jan, L. Y., & von Zastrow, M. (1999) · Neuron · doi:10.1016/s0896-6273(01)80032-5 · Cited by 413
Morphine-activated opioid receptors elude desensitization by β-arrestin
Whistler, J. L., & von Zastrow, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9914 · Cited by 370
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
Kohout, T. A., Lin, F.-T., Perry, S. J., Conner, D. A., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1601 · Cited by 367
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.
Sternini, C., Spann, M., Anton, B., Keith, D. E., Bunnett, N. W., von Zastrow, M., Evans, C., & Brecha, N. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9241 · Cited by 323
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Arden, J. R., Segredo, V., Wang, Z., Lameh, J., & Sadée, W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041636.x · Cited by 298
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice
Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10494.2002 · Cited by 264
Self-citationSim, L., Selley, D., Dworkin, S., & Childers, Sr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02684.1996 · Cited by 263
McPherson, J., Rivero, G., Baptist, M., Llorente, J., Al-Sabah, S., Krasel, C., Dewey, W. L., Bailey, C. P., Rosethorne, E. M., Charlton, S. J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066613 · Cited by 262
Identification and Characterization of Three New Alternatively Spliced μ-Opioid Receptor Isoforms
Pan, Y.-X., Xu, J., Bolan, E., Abbadie, C., Chang, A., Zuckerman, A., Rossi, G., & Pasternak, G. W. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12651-x · Cited by 254
Medical safety and side effects of methadone in tolerant individuals
Kreek, M. J. (1973) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1973.03220060039009 · Cited by 247
Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262789099 · Cited by 239
Luttrell, L. M., Daaka, Y., Della Rocca, G. J., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31648 · Cited by 233
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 229
Self-citationGroer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Self-citationRozenfeld, R., & Devi, L. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7793com · Cited by 220
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
The Effect of Intrinsic Efficacy on Opioid Tolerance
Duttaroy, A., & Yoburn, B. C. (1995) · Anesthesiology · doi:10.1097/00000542-199505000-00018 · Cited by 214
Kenakin, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.009 · Cited by 213
GPCR functional selectivity has therapeutic impact
Mailman, R. B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.002 · Cited by 208
Opioid tolerance: the clinical perspective
Collett, B. J. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.58 · Cited by 207
Crain, S. M., & Shen, K. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10540 · Cited by 204
Characterization of the G Protein-coupled Receptor Kinase GRK4
Premont, R. T., Macrae, A. D., Stoffel, R. H., Chung, N., Pitcher, J. A., Ambrose, C., Inglese, J., MacDonald, M. E., & Lefkowitz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6403 · Cited by 201
Raehal, K. M., & Bohn, L. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.003 · Cited by 189
Self-citationLin, F.-T., Daaka, Y., & Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31640 · Cited by 182
Schulz, S., Mayer, D., Pfeiffer, M., Stumm, R., Koch, T., & Höllt, V. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600334 · Cited by 180
Schmid, C. L., & Bohn, L. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 175
Self-citationWang, H.-Y., Friedman, E., Olmstead, M. C., & Burns, L. H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.003 · Cited by 174
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Self-citationAlvarez, V. A., Arttamangkul, S., Dang, V., Salem, A., Whistler, J. L., von Zastrow, M., Grandy, D. K., & Williams, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05769.2002 · Cited by 170
Receptor Endocytosis Counteracts the Development of Opioid Tolerance
Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L.-O., Wundrack, N., Beyer, A., Grecksch, G., & Höllt, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004994 · Cited by 167
Borgland, S. L., Connor, M., Osborne, P. B., Furness, J. B., & Christie, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300525200 · Cited by 165
Koch, T., Schulz, S., Pfeiffer, M., Klutzny, M., Schröder, H., Kahl, E., & Höllt, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100305200 · Cited by 160
Zheng, H., Loh, H. H., & Law, P.-Y. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039842 · Cited by 158
Sim‐Selley, L. J., Selley, D. E., Vogt, L. J., Childers, S. R., & Martin, T. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04555.2000 · Cited by 156
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
Melief, E. J., Miyatake, M., Bruchas, M. R., & Chavkin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000751107 · Cited by 154
Johnson, E. A., Oldfield, S., Braksator, E., Cuello, A. M. G., Couch, D., Hall, K. J., Mundell, S. J., Bailey, C. P., Kelly, E., & Henderson, G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022376 · Cited by 153
Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands
Harding, W. W., Tidgewell, K. J., Byrd, N., Cobb, H., Dersch, C. M., Butelman, E. R., Rothman, R. B., & Prisinzano, T. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048963m · Cited by 149
Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal Neurons
Haberstock-Debic, H., Kim, K., Yu, Y., & von Zastrow, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5045-04.2005 · Cited by 148
A Mitogen-activated Protein Kinase Pathway Is Required for μ-Opioid Receptor Desensitization
Polakiewicz, R. D., Schieferl, S. M., Dorner, L. F., Kansra, V. V., & Comb, M. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12402 · Cited by 142
Haberstock-Debic, H., Wein, M. N., Barrot, M., Colago, E. E. O., Rahman, Z. U., Neve, R. L., Pickel, V. M., Nestler, E. J., von Zastrow, M., & Svingos, A. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04324.2003 · Cited by 141
Kovoor, A., Celver, J. P., Wu, A., & Chavkin, C. (1998) · PubMed · Cited by 135
Melnikova, I. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3226 · Cited by 132
Stevens, C. W., & Yaksh, T. L. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21323-4 · Cited by 128
Abbadie, C., Pan, Y.-X., Drake, C. T., & Pasternak, G. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00248-7 · Cited by 128
Kouhen, R. E., Burd, A. L., Erickson, L. J., Chang, C., Law, P., & Loh, H. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009571200 · Cited by 125
Yuen, E. Y., Jiang, Q., Chen, P., Feng, J., & Yan, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801713200 · Cited by 125
Zeitz, K. P., Malmberg, A. B., Gilbert, H., & Basbaum, A. I. (2001) · Pain · doi:10.1016/s0304-3959(01)00353-0 · Cited by 118
Granados‐Soto, V., Kalcheva, I., Hua, X., Newton, A. C., & Yaksh, T. L. (2000) · Pain · doi:10.1016/s0304-3959(99)00281-x · Cited by 115
Urs, N. M., Daigle, T. L., & Caron, M. G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.186 · Cited by 113
Differential Activation and Trafficking of μ-Opioid Receptors in Brain Slices
Arttamangkul, S., Quillinan, N., Low, M. J., von Zastrow, M., Pintar, J. E., & Williams, J. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048512 · Cited by 112
Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions
Molinari, P., Vezzi, V., Sbraccia, M., Grò, M. C., Riitano, D., Ambrosio, C., Casella, I., & Costa, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059410 · Cited by 104
Bailey, C. P., Oldfield, S., Llorente, J., Caunt, C. J., Teschemacher, A., Roberts, L. D., McArdle, C. A., Smith, F., Dewey, W. L., Kelly, E., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00140.x · Cited by 103
Physiological and pharmacological implications of beta-arrestin regulation
Schmid, C. L., & Bohn, L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.005 · Cited by 103
Self-citationKoch, T., Kroslak, T., Mayer, P. E., Raulf, E., & Höllt, V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041767.x · Cited by 101
Koch, T., Brandenburg, L., Schulz, S., Liang, Y.-J., Klein, J., & Höllt, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206709200 · Cited by 101
Management of Expected and Unexpected Opioid-related Side Effects
Harris, J.-D. (2008) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b58eb · Cited by 101
Bailey, C. P., Llorente, J., Gabra, B. H., Smith, F. L., Dewey, W. L., Kelly, E., & Henderson, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06573.x · Cited by 100
Walwyn, W. M., Evans, C. J., & Hales, T. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1157-07.2007 · Cited by 99
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
Terman, G. W., Jin, W., Cheong, Y. P., Lowe, J., Caron, M. G., Lefkowitz, R. J., & Chavkin, C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705595 · Cited by 99
Melnikova, I. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2851 · Cited by 98
Distinct Domains of the μ-Opioid Receptor Control Uncoupling and Internalization
Celver, J. P., Xu, M., Jin, W., Lowe, J., & Chavkin, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.528 · Cited by 98
Bailey, C. P., Kelly, E., & Henderson, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004747 · Cited by 96
μ-Opioid Receptor Agonists Differentially Regulate the Expression of miR-190 and NeuroD
Zheng, H., Zeng, Y., Zhang, X., Chu, J., Loh, H. H., & Law, P. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060848 · Cited by 95
Maher, C. E., Eisenach, J. C., Pan, H., Xiao, R., & Childers, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03093-6 · Cited by 94
Sánchez‐Blázquez, P., Gómez-Serranillos, M. P., & Garzón, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00448-2 · Cited by 93
Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain
Erdtmann-Vourliotis, M., Mayer, P. E., Ammon, S., Riechert, U., & Höllt, V. (2001) · Molecular Brain Research · doi:10.1016/s0006-8993(01)03046-3 · Cited by 93
Recovery from μ-Opioid Receptor Desensitization after Chronic Treatment with Morphine and Methadone
Quillinan, N., Lau, E. K., Virk, M., von Zastrow, M., & Williams, J. T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4874-10.2011 · Cited by 92
Celver, J. P., Lowe, J., Kovoor, A., Gurevich, V. V., & Chavkin, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007437200 · Cited by 91
Mu opioid receptor regulation and opiate responsiveness
Raehal, K. M., & Bohn, L. (2005) · The AAPS Journal · doi:10.1208/aapsj070360 · Cited by 89
Self-citationAgonist-selective signaling is determined by the receptor location within the membrane domains
Zheng, H., Chu, J., Qiu, Y. L., Loh, H. H., & Law, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802253105 · Cited by 87
μ-Opioid receptor downregulation contributes to opioid tolerance in vivo
Stafford, K., Gomes, A. B., Shen, J., & Yoburn, B. C. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00525-1 · Cited by 87
Noble, F., & Cox, B. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15169.x · Cited by 86
An Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Li, H., & Whistler, J. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.052 · Cited by 84
Mu Opioid Receptor Activation of ERK1/2 Is GRK3 and Arrestin Dependent in Striatal Neurons
Macey, T. A., Lowe, J., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604278200 · Cited by 84
Crain, S. M., & Shen, K.-F. (1996) · Neurochemical Research · doi:10.1007/bf02532375 · Cited by 82
Pak, Y., O’Dowd, B. F., & George, S. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24961 · Cited by 82
Differential activation of G‐proteins byμ‐opioid receptor agonists
Saidak, Z., Blake-Palmer, K. G., Hay, D. L., Northup, J. K., & Glass, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706661 · Cited by 81
Kovoor, A., Celver, J. P., Wu, A. Y., & Chavkin, C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13072-6 · Cited by 80
Walker, E. A., & Young, A. M. (2001) · Psychopharmacology · doi:10.1007/s002130000620 · Cited by 78
Zheng, H., Chu, J., Zeng, Y., Loh, H. H., & Law, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112607 · Cited by 77
Hull, L. C., Llorente, J., Gabra, B. H., Smith, F. L., Kelly, E., Bailey, C. P., Henderson, G., & Dewey, W. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161455 · Cited by 73
Herkinorin Analogues with Differential β-Arrestin-2 Interactions
Tidgewell, K. J., Groer, C. E., Harding, W. W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701162g · Cited by 73
Self-citationChakrabarti, S., Law, P., & Loh, H. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010231.x · Cited by 71
Ueda, H., Inoue, M., & Matsumoto, T. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-09-02967.2001 · Cited by 70
Sanada, H., Yatabe, J., Midorikawa, S., Katoh, T., Hashimoto, S., Watanabe, T., Xu, J., Luo, Y., Wang, X., Zeng, C., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000222004.74872.17 · Cited by 69
Development of tolerance and sensitization to different opioid agonists in rats
Grecksch, G., Bartzsch, K., Widera, A., Becker, A., Höllt, V., & Koch, T. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0365-8 · Cited by 67
Phospholipase D2 modulates agonist‐induced µ‐opioid receptor desensitization and resensitization
Koch, T., Brandenburg, L., Liang, Y.-J., Schulz, S., Beyer, A., Schröder, H., & Höllt, V. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02189.x · Cited by 65
Enhanced μ-Opioid Responses in the Spinal Cord of Mice Lacking Protein Kinase Cγ Isoform
Narita, M., Mizoguchi, H., Suzuki, T., Narita, M., Dun, N. J., Imai, S., Yajima, Y., Nagase, H., Suzuki, T., & Tseng, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009716200 · Cited by 61
Sánchez‐Blázquez, P., Rodríguez‐Díaz, M., DeAntonio, I., & Garzón, J. (1999) · PubMed · Cited by 61
Role for the C-Terminus in Agonist-Induced μ Opioid Receptor Phosphorylation and Desensitization
Deng, H. B., Yu, Y., Pak, Y., O’Dowd, B. F., George, S. R., Surratt, C. K., Uhl, G. R., & Wang, J. B. (2000) · Biochemistry · doi:10.1021/bi991938b · Cited by 60
Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in Vivo
Patel, M. B., Patel, C. N., Rajashekara, V., & Yoburn, B. C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1464 · Cited by 60
Morphine-Induced μ-Opioid Receptor Desensitization
Dang, V. C., & Williams, J. T. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013185 · Cited by 59
Agonist-dependent μ-opioid receptor signaling can lead to heterologous desensitization
Chu, J., Zheng, H., Zhang, Y., Loh, H. H., & Law, P. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.003 · Cited by 58
Pawar, M., Kumar, P., Sunkaraneni, S., SIROHI, S. K., Walker, E. A., & Yoburn, B. C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.059 · Cited by 56
Chu, J., Zheng, H., Loh, H. H., & Law, P. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.004 · Cited by 56
Stevens, C. W., & Yaksh, T. L. (1990) · Survey of Anesthesiology · doi:10.1097/00132586-199010000-00036 · Cited by 56
Wolf, R., Koch, T., Schulz, S., Klutzny, M., Schröder, H., Raulf, E., Bühling, F., & Höllt, V. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.263 · Cited by 56
Li, Y.-T., Liu, X., Liu, C., Kang, J.-H., Yang, J.-Y., Pei, G., & Wu, C.-F. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030954 · Cited by 55
Smith, F. L., Javed, R. R., Elzey, M. J., & Dewey, W. L. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03170-6 · Cited by 53
Gβγ that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein
Wang, H., & Burns, L. H. (2006) · Journal of Neurobiology · doi:10.1002/neu.20286 · Cited by 52
Abbadie, C., Gultekin, S. H., & Pasternak, G. W. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00029 · Cited by 52
Frölich, N., Dees, C., Paetz, C., Ren, X., Lohse, M. J., Nikolaev, V. O., & Zenk, M. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.001 · Cited by 51
Fan, X., Zhang, J., Zhang, X., Yue, W., & Ma, L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00147-8 · Cited by 51
Feng, B., Li, Z., & Wang, J. B. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.069096 · Cited by 51
Agonist-Specific Regulation of μ-Opioid Receptor Desensitization and Recovery from Desensitization
Virk, M. S., & Williams, J. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042952 · Cited by 50
Role of Protein Kinase C (PKC) in Agonist‐Induced μ‐Opioid Receptor Down‐Regulation
Kramer, H. K., Simon, E. J., & Simon, E. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720585.x · Cited by 50
Inoue, M., & Ueda, H. (2000) · PubMed · Cited by 50
Gabra, B. H., Bailey, C. P., Kelly, E., Smith, F. L., Henderson, G., & Dewey, W. L. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.036 · Cited by 48
Hua, X.-Y., Moore, A., Malkmus, S. A., Murray, S., Dean, N. S., Yaksh, T. L., & Butler, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00157-4 · Cited by 48
Garzón, J., Rodríguez-Muñoz, M., & Sánchez‐Blázquez, P. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020222 · Cited by 47
Kenakin, T. (2009) · F1000 Biology Reports · doi:10.3410/b1-87 · Cited by 47
Agonists activate Gi1α or Gi2α fused to the human mu opioid receptor differently
Massotte, D., Brillet, K., Kieffer, B. L., & Milligan, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00946.x · Cited by 46
Sim‐Selley, L. J., Scoggins, K. L., Cassidy, M. P., Smith, L. A., Dewey, W. L., Smith, F. L., & Selley, D. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707328 · Cited by 43
Raehal, K. M., Schmid, C. L., Medvedev, I. O., Gainetdinov, R. R., Premont, R. T., & Bohn, L. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.011 · Cited by 43
Self-citationPrzewłocka, B., Sieja, A., Starowicz, K., Maj, M., Bilecki, W., & Przewłocki, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00246-x · Cited by 42
Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus
Bockstaele, E. J. V., & Commons, K. G. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00426-2 · Cited by 41
Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse
Madia, P. A., Dighe, S. V., SIROHI, S. K., Walker, E. A., & Yoburn, B. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1673-6 · Cited by 39
Ge, X., Qiu, Y. L., Loh, H. H., & Law, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024109 · Cited by 34
Wang, H., Chang, W., Hsu, C., Huang, P., Chow, Y., & Li, A. H.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01114-0 · Cited by 34
Yoburn, B. C., Purohit, V., Patel, K., & Zhang, Q. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.052 · Cited by 34
Wang, H. L. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00174-4 · Cited by 32
Clayton, C. C., Bruchas, M. R., Lee, M. L., & Chavkin, C. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060558 · Cited by 32
Hydromorphone efficacy and treatment protocol impact on tolerance and μ-opioid receptor regulation
Kumar, P., Sunkaraneni, S., SIROHI, S. K., Dighe, S. V., Walker, E. A., & Yoburn, B. C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.025 · Cited by 31
Inoue, M., & Ueda, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39282-1 · Cited by 26
Opioid Receptor Signal Transduction Mechanisms
Law, P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_9 · Cited by 23
Sánchez‐Blázquez, P., Rodríguez‐Díaz, M., DeAntonio, I., & Garzón, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35065-7 · Cited by 23
Selectivity for G Protein or Arrestin-Mediated Signaling
Bohn, L. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_5 · Cited by 11
Self-citation
Cited by
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
“In studies spanning more than a decade, researchers have shown that the interaction between MOR and barrestin2 may drive many of the unwanted side effects of MOR activation (Bohn et al., 1999; 2000; Bu et al., 2015; Li et al., 2009; Raehal et al., 2011; Raehal and Bohn, 2005).”
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
Endogenous and Exogenous Opioids in Pain
Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 502
Metadata
- Authors
- Raehal, K. M., Schmid, C. L., Groer, C. E., & Bohn, L. M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 63
- Issue
- 4
- Pages
- 1001-1019
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2107153432
- Cited by
- 256
- References
- 153
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.